Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

integrin

  • You have access
    Comparison of the RGD Motif–Containing αvβ6 Integrin–Binding Peptides SFLAP3 and SFITGv6 for Diagnostic Application in HNSCC
    Saskia Roesch, Thomas Lindner, Max Sauter, Anastasia Loktev, Paul Flechsig, Martin Müller, Walter Mier, Rolf Warta, Gerhard Dyckhoff, Christel Herold-Mende, Uwe Haberkorn and Annette Altmann
    Journal of Nuclear Medicine November 1, 2018, 59 (11) 1679-1685; DOI: https://doi.org/10.2967/jnumed.118.210013
  • You have access
    Novel “Add-On” Molecule Based on Evans Blue Confers Superior Pharmacokinetics and Transforms Drugs to Theranostic Agents
    Haojun Chen, Orit Jacobson, Gang Niu, Ido D. Weiss, Dale O. Kiesewetter, Yi Liu, Ying Ma, Hua Wu and Xiaoyuan Chen
    Journal of Nuclear Medicine April 1, 2017, 58 (4) 590-597; DOI: https://doi.org/10.2967/jnumed.116.182097
  • You have access
    68Ga-NOTA-PRGD2 PET/CT for Integrin Imaging in Patients with Lung Cancer
    Kun Zheng, Naixin Liang, Jingjing Zhang, Lixin Lang, Wei Zhang, Shanqing Li, Jun Zhao, Gang Niu, Fang Li, Zhaohui Zhu and Xiaoyuan Chen
    Journal of Nuclear Medicine December 1, 2015, 56 (12) 1823-1827; DOI: https://doi.org/10.2967/jnumed.115.160648
  • You have access
    18F-FPRGD2 PET/CT Imaging of Integrin αvβ3 in Renal Carcinomas: Correlation with Histopathology
    Nadia Withofs, Nicolas Signolle, Joan Somja, Pierre Lovinfosse, Eugène Mutijima Nzaramba, Frédéric Mievis, Fabrice Giacomelli, David Waltregny, Didier Cataldo, Sanjiv S. Gambhir and Roland Hustinx
    Journal of Nuclear Medicine March 1, 2015, 56 (3) 361-364; DOI: https://doi.org/10.2967/jnumed.114.149021
SNMMI

© 2025 SNMMI

Powered by HighWire